Venner, Christopher P
$147,354.00 CAD
≈ 23 months of average Canadian pay
- Department
- Canadian Institutes of Health Research
- Program
- —
- Recipient country
- Canada
- Fiscal year
- 2016-2017
- Agreement period
- March 1, 2017 – February 29, 2020
- Reference
- cihr-irsc:236-2016-2017-Q4-00337
Published purpose
A randomized phase II trial of bortezomib-based therapy plus doxycycline vs. bortezomib-based chemotherapy plus standard supportive therapy in cardiac AL amyloidosis
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions